GSK Bio
NEWS
Surface Oncology has agreed to grant exclusive worldwide licensing rights to GlaxoSmithKline for the development and commercialization of Surface Oncology’s SRF813, a fully human IgG1 antibody and immunotherapy designed to treat cancer.
The COVID-19 vaccine candidate developed by Sanofi and GlaxoSmithKline hit a snag that will delay the launch of a Phase III study due to an insufficient immune response in older trial patients.
Biopharma and life science companies and organizations strengthen their leadership teams and boards with these Movers & Shakers.
All eyes on the FDA as they review a COVID-19 vaccine, FDA approval of an Emergency Use Authorization to LabCorp’s home test kit for COVID-19, the first testing device that does not require a prescription and more news.
December is bringing frost in the North and plenty of cold, hard cash for these life sciences companies.
SciNeuro Pharmaceuticals, based in Shanghai, China, launched with a $100 million Series A financing.
With support from Peter Thiel, Eli Lilly partner AbCellera looks to join the NASDAQ with the biggest Canadian biotech debut on record.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Find out which biopharma companies are raking in cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.
JOBS
IN THE PRESS